With an increase in the outbreak of new diseases, the demand for contract research organizations(CRO) are increasing. Increasing investments in the R and D programmes, preference for outsourcing activities due to time and cost constraints and the patent expiration are key factors driving the growth of CRO market globally. The market is expected to grow further in the coming years. The pressure to maintain a regulatory environment and strict safety standard are the main reasons for the drug manufacturers to outsource projects to CROs. The global Contract Research Organization (CRO)services market is projected to reach USD 73.77 billion by 2025 from USD 47.77 billion in 2020, at a CAGR of 9.1 percent during the forecast period. Clinical research and services and oncology therapeutic area accounts for the largest share in global CRO market.
Industry Outlook in this issue presents a list of “Top 10 Contract Research Organizations - 2021” who have leveraged their extensive industry expertise and experience in bringing innovative products and services. The following list has been prepared after being closely scrutinized by a distinguished panel of judges...
Our subscribers play a decisive role in finalization of our annual list of "Top 10 Contract Research Organizations In India - 2021" by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
Pharmaceutical impurity & reference standards, metabolites & degradation products, genotoxic impurities, NCE’s & advanced intermediates, stable isotope labelled compounds, peptide and peptide impurities, analytical testing and services etc.
Provides Integrated Discovery, Development & Regulatory Services to Pharmaceutical, Biopharmaceutical, Agrochemical, Industrial Chemical, Herbal, Nutraceutical & Medical Device companies.
Offers preclinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies.
Works for development of recombinant proteins and monoclonal antibodies against clinically relevant targets through the integration of bioinformatics, recombinant DNA technology, proteomics and immunology using technologies.
Provides full range of clinical trial services to pharmaceutical, medical device and diagnostic customers, for all trial phases, registration and post-marketing trials.
Provides services to to Pharmaceuticals, Cosmetics, Personal care, OTC Products, Medical Devices, and Nutraceuticals & Herbals companies
Provides support in discovery, preclinical and clinical drug development
Provides clinical research services to pharmaceutical, biotechnology, medical device companies, academic and government organisations.
Have experience in delivering isolation, purification, chemical characterization and HPLC method development services
Provides research and testing services in the field of product safety assessment to clients throughout the world.
